MG01-T517

**MG01-T517** is an Inmunotek subcutaneous allergen-specific immunotherapy product comprising polymerized, glutaraldehyde-modified allergen extracts from six grass pollens and olive tree pollen. It is being evaluated as a disease-modifying treatment for grass- and olive pollen-sensitized patients with allergic rhinitis or allergic rhinoconjunctivitis, including patients with controlled mild-to-moderate allergic asthma. The product is intended to induce allergen-specific immune tolerance and reduce pollen-triggered allergic symptoms and rescue-medication requirements. ([clinicalresearch.eu](https://clinicalresearch.eu/trial/efficacy-and-safety-of-mg01-and-t517-drug-combination-in-patients-with-allergic-rhinitis-or-rhinoconjunctivitis-with-or-without-mild-moderate-asthma/))

Other names

MG01 + T517MG01_T517Mixture of modified allergen extracts of 6 grasses + modified allergen extract of olive pollenPolymerized grass + olive pollen allergoids